OHSU researchers collaborate on potential ‘game-changer’ for people with multiple sclerosis.
Evidence review leads to updated U.S. Preventative Services Task Force screening recommendations for asymptomatic children, pregnant women.
OHSU’s Center for Health & Healing Building 2 and the Gary & Christine Rood Family Pavilion offer an innovative approach to patient and family experience.
Native structure of a receptor may lead to finding the mechanism behind conditions like Alzheimer’s disease.
April 10, 2019
MEDIA ALERT: Ribbon-cutting event, followed by tours of the Center for Health & Healing Building 2 and the Gary & Christine Rood Family Pavilion.
99-year-old rural Oregonian may have been the oldest-known person with rare, life-threatening condition.
OHSU study is first to pinpoint a decrease in brain volume, potentially limiting lifetime learning ability.
Cancer clinical trials that use surrogate endpoints end up saving relatively little time, a new study finds.
As the most common infection among sick patients in intensive care units, OHSU will begin its clinical trial to test if a specialized breathing tube can reduce the risk of pneumonia in emergency intubation situations.
By acquiring OHSU's MolecularMD, the clinical research organization ICON, based in Dublin, Ireland, has expanded its laboratory offering in molecular diagnostic testing and brings expanded testing platforms.